China SXT Pharmaceuticals Inc.
SXTC | NASDAQ
$2.93
-$0.05 (-1.68%)
At close: Nov 5, 2026, 4:00 PM ET
$2.90
-$0.03 (-1.02%)
After-hours:
Nov 5, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Revenue | 1.07M | 1.74M | 1.93M | 1.97M | 2.6M | 4.78M |
Cost of Revenue | 889.35K | 1.37M | 1.37M | 1.55M | 1.35M | 1.94M |
Gross Profit | 183.28K | 367.43K | 553.97K | 426.27K | 1.25M | 2.84M |
Operating Income | -7.12M | -2.68M | -2.52M | -5.61M | -5.19M | -2.2M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -6.07M | -3.3M | -3.1M | -5.93M | -5.41M | -2.94M |
Net Income | -6.21M | -3.3M | -3.1M | -5.93M | -5.74M | -2.75M |
Selling & General & Admin | 7.13M | 3.05M | 3.07M | 6.03M | 6.44M | 5.04M |
Research & Development | 178.77K | 191.39K | 184.19K | n/a | n/a | n/a |
Other Expenses | n/a | -191.39K | -184.19K | n/a | n/a | n/a |
Operating Expenses | 7.31M | 3.05M | 3.07M | 6.03M | 6.44M | 5.04M |
Interest Expense | 62.97K | 648.22K | 544.28K | 476.78K | 36.7K | 1.62M |
Selling & Marketing Expenses | n/a | 289.86K | 433.57K | 387.45K | 924.54K | 1.59M |
Cost & Expenses | 8.2M | 4.42M | 4.44M | 7.58M | 7.79M | 6.97M |
Income Tax Expense | 130.84K | n/a | n/a | n/a | 328.15K | -192.68K |
Shares Outstanding (Basic) | 6.8K | 4.04K | 8.67K | 2.67K | 416 | 288 |
Shares Outstanding (Diluted) | 6.8K | 4.04K | 8.67K | 2.67K | 416 | 288 |
EPS (Basic) | -913 | -818 | -357 | -2.22K | -13.79K | -9.55K |
EPS (Diluted) | -913 | -818 | -357 | -2.22K | -13.79K | -9.55K |
EBITDA | -6.98M | -2.57M | -2.35M | -5.21M | -5.05M | -1.85M |
EBIT | -7.12M | -2.66M | -2.55M | -5.46M | -5.37M | -2.2M |
Depreciation & Amortization | 143.22K | 82.3K | 203.25K | 250.16K | 320.01K | 345.41K |
Add to Watchlist
Select watchlists to add or remove SXTC